Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of EnteroMedics Inc (ETRM)?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile gigantic failures like hedge funds’ recent losses in Valeant. Let’s take a closer look at what the funds we track think about EnteroMedics Inc (NASDAQ:ETRM) in this article.

EnteroMedics Inc investors should be aware of a decrease in support from the world’s most elite money managers of late. ETRM was in 5 hedge funds’ portfolios at the end of September. There were 6 hedge funds in our database with ETRM positions at the end of the previous quarter. At the end of this article we will also compare ETRM to other stocks including Biodel Inc (NASDAQ:BIOD), Rubicon Technology, Inc. (NASDAQ:RBCN), and Echelon Corporation (NASDAQ:ELON) to get a better sense of its popularity.

Follow Reshape Lifesciences Inc. (NASDAQ:RSLS)
Trade (NASDAQ:RSLS) Now!

Keeping this in mind, we’re going to take a gander at the recent action encompassing EnteroMedics Inc (NASDAQ:ETRM).

Hedge fund activity in EnteroMedics Inc (NASDAQ:ETRM)

At the end of the third quarter, a total of 5 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -17% from the second quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Sabby Capital, managed by Hal Mintz, holds the most valuable position in EnteroMedics Inc (NASDAQ:ETRM). Sabby Capital has a $0.5 million position in the stock, comprising less than 0.1% of its 13F portfolio. Sitting at the No. 2 spot is DAFNA Capital Management, led by Nathan Fischel, holding a $0.1 million position; 0.1% of its 13F portfolio is allocated to the company. Remaining members of the smart money with similar optimism consist of Thomas Bailard’s Bailard Inc, Israel Englander’s Millennium Management and Jacob Gottlieb’s Visium Asset Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.